N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen
C20H22N4O2S2 — CID 144980284
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen
N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen (PubChem CID 144980284) has the molecular formula C20H22N4O2S2 and a molecular weight of 414.56 g/mol. Its IUPAC name is N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen.
Molecular Properties
| Compound Name | N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen |
|---|---|
| PubChem CID | 144980284 |
| Molecular Formula | C20H22N4O2S2 |
| Molecular Weight | 414.56 g/mol |
| Exact Mass | 414.12 |
| IUPAC Name | N-(2-methyl-1,3-benzoxazol-6-yl)-2-piperidin-1-yl-7H-thiopyrano[2,3-d][1,3]thiazole-5-carboxamide;molecular hydrogen |
| SMILES | Cc1nc2ccc(NC(=O)C3=CCc4sc(N5CCCCC5)nc4S3)cc2o1.[H][H] |
| InChI | InChI=1S/C20H20N4O2S2.H2/c1-12-21-14-6-5-13(11-15(14)26-12)22-18(25)16-7-8-17-19(27-16)23-20(28-17)24-9-3-2-4-10-24;/h5-7,11H,2-4,8-10H2,1H3,(H,22,25);1H |
| InChIKey | KZTSWHVRBBQKRA-UHFFFAOYSA-N |
| XLogP | 5.00 |
| TPSA | 71.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.56 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144980284 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.